Dr Keir Andrew Bexar Fowler, MD | |
1650 Cowles St, Fairbanks, AK 99701 | |
(907) 458-5660 | |
Not Available |
Full Name | Dr Keir Andrew Bexar Fowler |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 26 Years |
Location | 1650 Cowles St, Fairbanks, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700991163 | NPI | - | NPPES |
MD2639 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | A81767 (California) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | 5185 (Alaska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Fairbanks Memorial Hospital | Fairbanks, AK | Hospital |
South Peninsula Hospital | Homer, AK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Radiology Consultants A Professional Corp | 0749173029 | 10 |
South Peninsula Hospital Inc | 5395636930 | 43 |
Alaska Native Tribal Health Consortium | 6709780265 | 457 |
Tanana Chiefs Conference | 9537050109 | 100 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.The new results from the OPTIMAL trial were reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested
People with anorexia nervosa and with body dysmorphic disorder have similar abnormalities in their brains that affect their ability to process visual information, a new UCLA study reveals.
Eating smart, not eating less, may be the key to losing weight. A year-long clinical trial by Penn State researchers shows that diets focusing on foods that are low in calorie density can promote healthy weight loss while helping people to control hunger.
› Verified 3 days ago
Entity Name | Radiology Consultants A Professional Corp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124056734 PECOS PAC ID: 0749173029 Enrollment ID: O20040203000194 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.The new results from the OPTIMAL trial were reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested
People with anorexia nervosa and with body dysmorphic disorder have similar abnormalities in their brains that affect their ability to process visual information, a new UCLA study reveals.
Eating smart, not eating less, may be the key to losing weight. A year-long clinical trial by Penn State researchers shows that diets focusing on foods that are low in calorie density can promote healthy weight loss while helping people to control hunger.
› Verified 3 days ago
Entity Name | South Peninsula Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679566269 PECOS PAC ID: 5395636930 Enrollment ID: O20040323000583 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.The new results from the OPTIMAL trial were reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested
People with anorexia nervosa and with body dysmorphic disorder have similar abnormalities in their brains that affect their ability to process visual information, a new UCLA study reveals.
Eating smart, not eating less, may be the key to losing weight. A year-long clinical trial by Penn State researchers shows that diets focusing on foods that are low in calorie density can promote healthy weight loss while helping people to control hunger.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Keir Andrew Bexar Fowler, MD Po Box 70378, Fairbanks, AK 99707-0378 Ph: (907) 456-2784 | Dr Keir Andrew Bexar Fowler, MD 1650 Cowles St, Fairbanks, AK 99701 Ph: (907) 458-5660 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.The new results from the OPTIMAL trial were reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested
People with anorexia nervosa and with body dysmorphic disorder have similar abnormalities in their brains that affect their ability to process visual information, a new UCLA study reveals.
Eating smart, not eating less, may be the key to losing weight. A year-long clinical trial by Penn State researchers shows that diets focusing on foods that are low in calorie density can promote healthy weight loss while helping people to control hunger.
› Verified 3 days ago
Claire Margaret Waite, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5660 | |
David L Evans, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5660 | |
Dr. Jessica Ellen Panko, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-452-6464 | |
Dr. Jedidiah Jonah Malan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 815 2nd Ave, Suite 202, Fairbanks, AK 99701 Phone: 316-519-7664 | |
Theresa Joanne Shanley, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5660 | |
Mark Nathan Burton, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5660 | |
Joel Marquess, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 704-355-0221 Fax: 704-355-0770 |